PDB Short entry for 3BVN HEADER IMMUNE SYSTEM 07-JAN-08 3BVN TITLE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE TITLE 2 LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B*1402 ALPHA CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B, E; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: LATENT MEMBRANE PROTEIN 2 PEPTIDE; COMPND 11 CHAIN: C, F; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: HLA-B; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PHN; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 GENE: B2M; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: XA90; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PHN; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 OTHER_DETAILS: PEPTIDE PLMP2 CHEMICALLY SYNTHESIZED KEYWDS MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, KEYWDS 2 HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING KEYWDS 3 SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE KEYWDS 4 RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, KEYWDS 5 SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, KEYWDS 6 MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE KEYWDS 7 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.KUMAR,A.VAHEDI-FARIDI,W.SAENGER,B.UCHANSKA-ZIEGLER,A.ZIEGLER REVDAT 4 30-AUG-23 3BVN 1 SEQADV REVDAT 3 10-NOV-09 3BVN 1 JRNL REVDAT 2 18-AUG-09 3BVN 1 JRNL REVDAT 1 03-FEB-09 3BVN 0 JRNL AUTH P.KUMAR,A.VAHEDI-FARIDI,W.SAENGER,E.MERINO, JRNL AUTH 2 J.A.LOPEZ DE CASTRO,B.UCHANSKA-ZIEGLER,A.ZIEGLER JRNL TITL STRUCTURAL BASIS FOR T CELL ALLOREACTIVITY AMONG THREE JRNL TITL 2 HLA-B14 AND HLA-B27 ANTIGENS JRNL REF J.BIOL.CHEM. V. 284 29784 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19617632 JRNL DOI 10.1074/JBC.M109.038497 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.KUMAR,A.VAHEDI-FARIDI,E.MERINO,J.A.LOPEZ DE CASTRO,A.VOLZ, REMARK 1 AUTH 2 A.ZIEGLER,W.SAENGER,B.UCHANSKA-ZIEGLER REMARK 1 TITL EXPRESSION, PURIFICATION AND PRELIMINARY X-RAY REMARK 1 TITL 2 CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN MAJOR REMARK 1 TITL 3 HISTOCOMPATIBILITY ANTIGEN HLA-B*1402 IN COMPLEX WITH A REMARK 1 TITL 4 VIRAL PEPTIDE AND WITH A SELF-PEPTIDE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 63 631 2007 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 17620730 REMARK 1 DOI 10.1107/S1744309107029077 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.8 REMARK 3 NUMBER OF REFLECTIONS : 24383 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1198 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 251 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.630 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BVN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046012. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : SI-111 CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26731 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.8700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1UXW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-22%(W/V) PEG 20 000, 0.1 M HEPES REMARK 280 BUFFER PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.97650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4550 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4640 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET B 0 REMARK 465 MET D 0 REMARK 465 MET E 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 105 N - CA - C ANGL. DEV. = -15.7 DEGREES REMARK 500 ASP A 106 N - CA - C ANGL. DEV. = -20.1 DEGREES REMARK 500 THR A 225 N - CA - C ANGL. DEV. = 17.4 DEGREES REMARK 500 LEU D 81 CA - CB - CG ANGL. DEV. = 14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -123.35 57.22 REMARK 500 PHE A 33 -6.91 -140.12 REMARK 500 ILE A 52 2.61 -68.02 REMARK 500 ASP A 106 -35.43 151.27 REMARK 500 ARG A 111 145.46 -175.29 REMARK 500 ASN A 114 98.91 -162.16 REMARK 500 TYR A 123 -72.06 -118.36 REMARK 500 ASP A 220 171.54 59.67 REMARK 500 GLN A 226 62.44 -108.16 REMARK 500 ASP A 227 -13.23 -145.32 REMARK 500 ARG A 239 -17.77 87.92 REMARK 500 PRO A 276 -1.47 -49.02 REMARK 500 ARG D 17 49.79 -148.10 REMARK 500 ASP D 29 -121.11 59.30 REMARK 500 ARG D 48 12.29 -140.47 REMARK 500 ASN D 114 83.71 -168.77 REMARK 500 LEU D 130 19.06 58.81 REMARK 500 ARG D 239 -15.06 86.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS DBREF 3BVN A 1 277 UNP Q56H30 Q56H30_HUMAN 10 286 DBREF 3BVN B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3BVN C 1 9 UNP P13285 LMP2_EBV 236 244 DBREF 3BVN D 1 277 UNP Q56H30 Q56H30_HUMAN 10 286 DBREF 3BVN E 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3BVN F 1 9 UNP P13285 LMP2_EBV 236 244 SEQADV 3BVN MET A 0 UNP Q56H30 INITIATING METHIONINE SEQADV 3BVN MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 3BVN MET D 0 UNP Q56H30 INITIATING METHIONINE SEQADV 3BVN MET E 0 UNP P61769 INITIATING METHIONINE SEQRES 1 A 278 MET GLY SER HIS SER MET ARG TYR PHE TYR THR ALA VAL SEQRES 2 A 278 SER ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE SER VAL SEQRES 3 A 278 GLY TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER SEQRES 4 A 278 ASP ALA ALA SER PRO ARG GLU GLU PRO ARG ALA PRO TRP SEQRES 5 A 278 ILE GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG ASN THR SEQRES 6 A 278 GLN ILE CYS LYS THR ASN THR GLN THR ASP ARG GLU SER SEQRES 7 A 278 LEU ARG ASN LEU ARG GLY TYR TYR ASN GLN SER GLU ALA SEQRES 8 A 278 GLY SER HIS THR LEU GLN TRP MET TYR GLY CYS ASP VAL SEQRES 9 A 278 GLY PRO ASP GLY ARG LEU LEU ARG GLY TYR ASN GLN PHE SEQRES 10 A 278 ALA TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP SEQRES 11 A 278 LEU SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE SEQRES 12 A 278 THR GLN ARG LYS TRP GLU ALA ALA ARG GLU ALA GLU GLN SEQRES 13 A 278 LEU ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU SEQRES 14 A 278 ARG ARG HIS LEU GLU ASN GLY LYS GLU THR LEU GLN ARG SEQRES 15 A 278 ALA ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SEQRES 16 A 278 SER ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY SEQRES 17 A 278 PHE TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP SEQRES 18 A 278 GLY GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR SEQRES 19 A 278 ARG PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA SEQRES 20 A 278 VAL VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS SEQRES 21 A 278 HIS VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU SEQRES 22 A 278 ARG TRP GLU PRO SER SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 ARG ARG ARG TRP ARG ARG LEU THR VAL SEQRES 1 D 278 MET GLY SER HIS SER MET ARG TYR PHE TYR THR ALA VAL SEQRES 2 D 278 SER ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE SER VAL SEQRES 3 D 278 GLY TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER SEQRES 4 D 278 ASP ALA ALA SER PRO ARG GLU GLU PRO ARG ALA PRO TRP SEQRES 5 D 278 ILE GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG ASN THR SEQRES 6 D 278 GLN ILE CYS LYS THR ASN THR GLN THR ASP ARG GLU SER SEQRES 7 D 278 LEU ARG ASN LEU ARG GLY TYR TYR ASN GLN SER GLU ALA SEQRES 8 D 278 GLY SER HIS THR LEU GLN TRP MET TYR GLY CYS ASP VAL SEQRES 9 D 278 GLY PRO ASP GLY ARG LEU LEU ARG GLY TYR ASN GLN PHE SEQRES 10 D 278 ALA TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP SEQRES 11 D 278 LEU SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE SEQRES 12 D 278 THR GLN ARG LYS TRP GLU ALA ALA ARG GLU ALA GLU GLN SEQRES 13 D 278 LEU ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU SEQRES 14 D 278 ARG ARG HIS LEU GLU ASN GLY LYS GLU THR LEU GLN ARG SEQRES 15 D 278 ALA ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SEQRES 16 D 278 SER ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY SEQRES 17 D 278 PHE TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP SEQRES 18 D 278 GLY GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR SEQRES 19 D 278 ARG PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA SEQRES 20 D 278 VAL VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS SEQRES 21 D 278 HIS VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU SEQRES 22 D 278 ARG TRP GLU PRO SER SEQRES 1 E 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 F 9 ARG ARG ARG TRP ARG ARG LEU THR VAL FORMUL 7 HOH *251(H2 O) HELIX 1 1 PRO A 50 GLN A 54 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ALA A 139 ALA A 150 1 12 HELIX 4 4 ARG A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLU A 253 GLN A 255 5 3 HELIX 8 8 ALA D 49 GLU D 53 5 5 HELIX 9 9 GLY D 56 TYR D 85 1 30 HELIX 10 10 ALA D 139 ALA D 150 1 12 HELIX 11 11 ARG D 151 GLY D 162 1 12 HELIX 12 12 GLY D 162 GLY D 175 1 14 HELIX 13 13 GLY D 175 GLN D 180 1 6 HELIX 14 14 GLU D 253 GLN D 255 5 3 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N GLY A 26 O PHE A 33 SHEET 4 A 8 HIS A 3 VAL A 12 -1 N ARG A 6 O TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 O TRP A 97 N TYR A 9 SHEET 6 A 8 LEU A 109 TYR A 118 -1 O GLN A 115 N MET A 98 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O TYR A 123 N PHE A 116 SHEET 8 A 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 B 4 LYS A 186 PRO A 193 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 B 4 PHE A 241 PRO A 250 -1 O VAL A 249 N ALA A 199 SHEET 4 B 4 THR A 228 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 PRO A 193 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 C 4 PHE A 241 PRO A 250 -1 O VAL A 249 N ALA A 199 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 3 THR A 214 ARG A 219 0 SHEET 2 D 3 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 3 D 3 LEU A 270 LEU A 272 -1 O LEU A 272 N CYS A 259 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 E 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 G 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 H 8 GLU D 46 PRO D 47 0 SHEET 2 H 8 THR D 31 ASP D 37 -1 N ARG D 35 O GLU D 46 SHEET 3 H 8 ARG D 21 VAL D 28 -1 N SER D 24 O PHE D 36 SHEET 4 H 8 HIS D 3 VAL D 12 -1 N ARG D 6 O TYR D 27 SHEET 5 H 8 THR D 94 VAL D 103 -1 O LEU D 95 N ALA D 11 SHEET 6 H 8 LEU D 109 TYR D 118 -1 O LEU D 110 N ASP D 102 SHEET 7 H 8 LYS D 121 LEU D 126 -1 O TYR D 123 N PHE D 116 SHEET 8 H 8 TRP D 133 ALA D 135 -1 O THR D 134 N ALA D 125 SHEET 1 I 4 LYS D 186 PRO D 193 0 SHEET 2 I 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 I 4 PHE D 241 PRO D 250 -1 O ALA D 245 N CYS D 203 SHEET 4 I 4 GLU D 229 LEU D 230 -1 N GLU D 229 O ALA D 246 SHEET 1 J 4 LYS D 186 PRO D 193 0 SHEET 2 J 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 J 4 PHE D 241 PRO D 250 -1 O ALA D 245 N CYS D 203 SHEET 4 J 4 ARG D 234 PRO D 235 -1 N ARG D 234 O GLN D 242 SHEET 1 K 4 GLU D 222 ASP D 223 0 SHEET 2 K 4 THR D 214 ARG D 219 -1 N ARG D 219 O GLU D 222 SHEET 3 K 4 TYR D 257 GLN D 262 -1 O HIS D 260 N THR D 216 SHEET 4 K 4 LEU D 270 LEU D 272 -1 O LEU D 272 N CYS D 259 SHEET 1 L 4 LYS E 6 SER E 11 0 SHEET 2 L 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 L 4 PHE E 62 PHE E 70 -1 O TYR E 66 N CYS E 25 SHEET 4 L 4 GLU E 50 HIS E 51 -1 N GLU E 50 O TYR E 67 SHEET 1 M 4 LYS E 6 SER E 11 0 SHEET 2 M 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 M 4 PHE E 62 PHE E 70 -1 O TYR E 66 N CYS E 25 SHEET 4 M 4 SER E 55 PHE E 56 -1 N SER E 55 O TYR E 63 SHEET 1 N 4 GLU E 44 ARG E 45 0 SHEET 2 N 4 GLU E 36 LYS E 41 -1 N LYS E 41 O GLU E 44 SHEET 3 N 4 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 4 N 4 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.00 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 SSBOND 4 CYS D 101 CYS D 164 1555 1555 2.03 SSBOND 5 CYS D 203 CYS D 259 1555 1555 2.04 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.02 CISPEP 1 TYR A 209 PRO A 210 0 3.79 CISPEP 2 HIS B 31 PRO B 32 0 0.17 CISPEP 3 TYR D 209 PRO D 210 0 -2.74 CISPEP 4 HIS E 31 PRO E 32 0 -0.33 CRYST1 53.383 79.953 105.440 90.00 99.51 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018733 0.000000 0.003138 0.00000 SCALE2 0.000000 0.012507 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009616 0.00000